Efficacy validation of synthesized retinol derivatives In vitro: stability, toxicity, and activity - PubMed (original) (raw)
Efficacy validation of synthesized retinol derivatives In vitro: stability, toxicity, and activity
Hye-Sook Han et al. Bioorg Med Chem. 2003.
Abstract
Retinol (vitamin A) is used as an antiwrinkle agent in the cosmetics industry. However, its photo-instability makes it unsuitable for use in general cosmetic formulations. To improve the photo-stability of retinol, three derivatives (3, 4, and 5) were synthesized and their biological activities were analyzed. 1H NMR and HPLC analysis indicated that derivatives 3 and 5 were much more stable than retinol under our sunlight exposure conditions. When human adult fibroblasts were treated, the IC(50) of derivative 3 was 96 microM, which is similar to that of retinol, as determined by the MTT assay. Derivatives 4 and 5 were 2.5 and 8 times more toxic than retinol, respectively. At 1 microM treatment, like retinol, derivatives 3 and 4 were specifically active for RARalpha out of six retinoid receptors (RAR/RXRalpha, beta, gamma). Dose-dependent analysis confirmed that derivative 4 was as active as retinol and the other two derivatives were less active for RARalpha. The effect of our derivatives on the expression of collagenase, an indicator of wrinkle formation, was measured using the transient co-expression of c-Jun and RT-PCR in HaCaT cells. Collagenase promoter activity, which is increased by c-Jun expression, was reduced 42% by retinol treatment. The other derivatives inhibited collagenase promoter activity similarly. These results were further confirmed by RT-PCR analysis of the collagenase gene. Taken together, our results suggest that retinol derivative 3 is a promising antiwrinkle agent based on its higher photo-stability, lower RARalpha activity (possibly indicating reduced side effects), and similar effect on collagenase expression.
Similar articles
- Retinyl methyl ether down-regulates activator protein 1 transcriptional activation in breast cancer cells.
Agadir A, Shealy YF, Hill DL, Zhang X. Agadir A, et al. Cancer Res. 1997 Aug 15;57(16):3444-50. Cancer Res. 1997. PMID: 9270011 - Retinyl methyl ether: binding to transport proteins and effect on transcriptional regulation.
Sani BP, Zhang X, Hill DL, Shealy YF. Sani BP, et al. Biochem Biophys Res Commun. 1996 Jun 14;223(2):293-8. doi: 10.1006/bbrc.1996.0887. Biochem Biophys Res Commun. 1996. PMID: 8670275 - Chemical stability and in vitro and clinical efficacy of a novel hybrid retinoid derivative, bis-retinamido methylpentane.
Kim KH, Lim DG, Lim JY, Kim NA, Park SH, Cho JH, Shin BS, Jeong SH. Kim KH, et al. Int J Pharm. 2015 Nov 10;495(1):93-105. doi: 10.1016/j.ijpharm.2015.08.081. Epub 2015 Sep 4. Int J Pharm. 2015. PMID: 26325317 Clinical Trial. - A new metabolite of retinol: all-trans-4-oxo-retinol as a receptor activator and differentiation agent.
Ross SA, De Luca LM. Ross SA, et al. Nutr Rev. 1996 Nov;54(11 Pt 1):355-6. doi: 10.1111/j.1753-4887.1996.tb03802.x. Nutr Rev. 1996. PMID: 9110564 Review. - Comparative assessment of the toxicology of vitamin A and retinoids in man.
Biesalski HK. Biesalski HK. Toxicology. 1989 Jul 17;57(2):117-61. doi: 10.1016/0300-483x(89)90161-3. Toxicology. 1989. PMID: 2665185 Review.
Cited by
- Use of Retinoids in Topical Antiaging Treatments: A Focused Review of Clinical Evidence for Conventional and Nanoformulations.
Milosheska D, Roškar R. Milosheska D, et al. Adv Ther. 2022 Dec;39(12):5351-5375. doi: 10.1007/s12325-022-02319-7. Epub 2022 Oct 11. Adv Ther. 2022. PMID: 36220974 Free PMC article. Review. - Enhancing Topical Pharmacotherapy for Acne and Rosacea: Vehicle Choices and Outcomes.
Green LJ, Lain E, Prunty T, Rhoades R. Green LJ, et al. J Clin Aesthet Dermatol. 2022 May;15(5):36-40. J Clin Aesthet Dermatol. 2022. PMID: 35642224 Free PMC article. Review. - Triple nanoemulsion potentiates the effects of topical treatments with microencapsulated retinol and modulates biological processes related to skin aging.
Afornali A, Vecchi Rd, Stuart RM, Dieamant G, Oliveira LL, Brohem CA, Feferman IH, Fabrício LH, Lorencini M. Afornali A, et al. An Bras Dermatol. 2013 Nov-Dec;88(6):930-6. doi: 10.1590/abd1806-4841.20132208. An Bras Dermatol. 2013. PMID: 24474102 Free PMC article. - Retinoids in the treatment of skin aging: an overview of clinical efficacy and safety.
Mukherjee S, Date A, Patravale V, Korting HC, Roeder A, Weindl G. Mukherjee S, et al. Clin Interv Aging. 2006;1(4):327-48. doi: 10.2147/ciia.2006.1.4.327. Clin Interv Aging. 2006. PMID: 18046911 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous